AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others,...
from NDTV News - Topstories https://ift.tt/3qmK4Lw
from NDTV News - Topstories https://ift.tt/3qmK4Lw
Comments
Post a Comment